ATARA BIOTHERAPEUTICS, INC.
Cash Flow Statement
| Line Item | Sep 2023 | Jun 2023 | Mar 2023 | Sep 2022 | Jun 2022 | Mar 2022 | Sep 2021 | Jun 2021 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-69.8M | $-71.1M | $-74.8M | $-84.1M | $18.5M | $-88.1M | $-84.7M | $-83.8M |
| Depreciation & Amortization | — | — | $1.2M | $1.4M | $1.4M | $1.6M | $2.3M | $2.3M |
| Depreciation | $900.0K | $900.0K | $900.0K | $1.1M | $1.4M | $1.5M | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | $11.8M | — | — | $14.3M | — | — |
| Net Cash from Operating Activities | $-51.3M | $-52.8M | $-38.4M | $-65.1M | $-64.0M | $-84.5M | $-59.0M | $-61.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $281.0K | $499.0K | $399.0K | $132.0K | $1.4M | $2.6M | $3.9M | $2.1M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $-6.0M | — | — | $60.2M | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $235.0K | — | — | $19.9M | — | — |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-51.6M | $-53.3M | $-38.8M | $-65.2M | $-65.4M | $-87.1M | $-62.8M | $-63.6M |